Rovalpituzumab tesirine for treating small-cell lung cancer after 2 therapies [ID1288]
Discontinued
Reference number: GID-TA10212
As you will be aware the Department for Health and Social Care has asked NICE to carry out a Single Technology Appraisal of rovalpituzumab tesirine for treating small-cell lung cancer after 2 therapies.
Following on from an update from the company, the timelines for this appraisal are to be confirmed.
As this appraisal has been referred to NICE we will continue to monitor any development and will update interested parties as and when the situation changes.